Genetic counseling for patients considering screening and diagnosis for chromosomal abnormalities.
Obstetrics & Gynecology
Clinics in laboratory medicine
Decision Making, Female, Genetic Counseling, Humans, Pregnancy, Prenatal Diagnosis, Risk Assessment
With the introduction of cell-free DNA screening for fetal aneuploidy and chromosomal microarray for prenatal diagnostic testing, options for pregnant women have become increasingly complex. Discussions regarding options for prenatal testing for aneuploidy should occur prior to any testing and should include pertinent risks and benefits of each alternative test. There is no single screening or diagnostic test option that is the right choice for all patients; patient decisions should be based on each individual woman's values and preferences after a discussion of all options.
Chard, Renée L. and Norton, Mary E, "Genetic counseling for patients considering screening and diagnosis for chromosomal abnormalities." (2016). Maine Medical Center. 412.